Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...
Pushing bioprocessing ahead depends on addressing a collection of complex tasks. “Whether it’s cell therapies, biologics, or any of the advanced therapies, you see a lot of drive towards Bioprocessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results